Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Expand chart
Data: DRC Ministry of Health; Chart: Andrew Witherspoon and Harry Stevens/Axios

Despite having more tools to combat Ebola than ever before, the disease continues to spread to new parts of the Democratic Republic of the Congo — partly as a result of continued lack of trust from the public, according to several experts from Doctors without Borders (MSF).

Why it matters: Many now believe the outbreak will last at least a year from its Aug. 1 start, with some saying it could become endemic to the area. But public health officials are hoping that once they earn the population's trust, they'll be able to halt the outbreak with old-fashioned contact tracing combined with new tools like fast diagnostics, experimental treatments and an experimental vaccine.

What they're saying: Several experts with MSF, which has more than 200 staff members working on the ground in the DRC, spoke at a press conference earlier this week. They said the combination of the security situation, nasty disease and community distrust amounts to a "very frustrating" situation.

  • MSF project coordinator Karin Huster said that while this is DRC's 10th Ebola outbreak and its federal public health officials are experienced, the communities where this outbreak is centered have never seen Ebola before, and often mistake it for malaria.
  • Another issue is that this region of DRC has suffered from instability and rebel-related violence for quite some time, and the influx of federal officials and foreign organizations recently has fostered a suspicion of their motives.
  • MSF physician Brian D'Cruz, who has worked on Ebola outbreaks elsewhere, said he hasn't seen this level of distrust before, and that it's leading people to seek treatment too late in the infection process.
  • In a video testimony, a Congolese woman told her story of contracting Ebola but delaying her visit to the Ebola Treatment Center because she had heard rumors that the ETC "zipped you up in body bags before you were even dead."

The treatment trials have also been hampered by the security situation, Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, told Axios.

  • Currently, the trial is actively accruing patients and administering experimental treatments under close observation.
  • The study is designed to enroll 125 patients in each arm of the study, for a total of 500 participants. The trial may be adapted to continue enrollment across more than one outbreak and in several countries if necessary, so the researchers can gather enough data to evaluate safety and efficacy, Fauci said.
  • However, the trial in DRC only has 56 patients so far. "The security issues currently encountered in DRC have made it difficult to conduct the trial at the pace we had hoped," Fauci said.

But, the ring vaccination appears to be helping, although no one is 100% sure since it's not part of a randomized trial, Fauci tells Axios.

  • "It's likely things would be much more out of control" without the vaccine, Fauci said.
  • As of Jan. 30, there had been 70,611 people innoculated with Merck's rVSV-ZEBOV vaccine, the only experimental vaccine approved for use in DRC, according to the Ministry of Health.
  • However, that could change in the future, as an official from the World Health Organization indicated in a tweet that they are considering starting two randomized trials with other vaccines.

Meanwhile, a group of scientists in a Nature opinion piece say that Ebola diagnostics tests must be made more easily available.

Go deeper: Read Axios' full Ebola coverage.

Go deeper

Pew: Over 80% of Asian adults say violence against them is increasing

Photo: Spencer Platt/Getty Images

More than 80% of Asian adults say that violence against them is increasing, according to a new Pew Research Center survey.

The big picture: The survey, conducted April 5-11, comes after the recent shootings in Atlanta in which eight people, including six Asian women were killed, as well as a yearlong spike in hate incidents against the Asian American and Pacific Islander (AAPI) community.

Danger lurks in the Democrats' police talk

House Speaker Nancy Pelosi and House Democrats celebrate last June after they passed the George Floyd Policing Act. Photo: Ting Shen/Xinhua via Getty Images

As Congress forges ahead with police reform legislation, Democratic operatives are warning lawmakers to steer clear of any defund-the-police rhetoric since it could hurt them in the midterms.

Why it matters: President Biden and his fellow Democrats say Congress needs to pass the George Floyd Policing Act, which would ban chokeholds, prohibit no-knock warrants and generally make it easier to hold officers accountable for misconduct.

Exclusive: Harris meets Guatemalan president Monday, travels in June

Photo: Jim Watson/AFP via Getty Images

Vice President Kamala Harris will meet virtually Monday with Guatemalan President Alejandro Giammattei to discuss solutions to the surge of migration, and she'll visit the region in June, a senior White House official told Axios.

Why it matters: The administration is taking a multi-pronged approach to solving the problem and also hopes to announce details about its plan for investing aid in Central America on Monday — although a final dollar amount has yet to be decided.